X

Trial Profile

Biobehavioral Studies of Opioid Seeking: Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 05 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Buprenorphine/naloxone (Primary) ; Hydrocortisone; Morphine; Yohimbine
Indications Heroin-related disorders; Opioid-related disorders
Focus Therapeutic Use
Acronyms BOS

Most Recent Events

06 Nov 2020 Protocol of the trial has been amended with changes in the primary purpose from Treatment to Basic science, number of arms increased from 2 to 8,Interventional Study Model has been changed from parallel to crossover.
06 Nov 2020 Status changed from recruiting to completed.
21 Jan 2020 Planned End Date changed from 1 Jun 2020 to 1 Aug 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com